The tumor-bearing state induces augmented responses of organ-associated lymphocytes to high-dose interleukin-2 therapy in mice Y. AsanoK. KanedaK. Higashino ORIGINAL ARTICLE Pages: 63 - 70
Restoration of macrophage tumoricidal activity by bleomycin correlates with the decreased production of transforming growth factor β in rats bearing KDH-8 hepatoma cells L. YuanMasanobu KobayashiM. Hosokawa ORIGINAL ARTICLE Pages: 71 - 76
Treatment of recurrent glioma with intracavitary alloreactive cytotoxic T lymphocytes and interleukin-2 C. A. KruseLinda CepedaKevin O. Lillehei ORIGINAL ARTICLE Pages: 77 - 87
Sequence variation in the monoclonal-antibody-U36-defined CD44v6 epitope Nicole L. W. Van HalG. A. M. S. Van DongenR. H. Brakenhoff ORIGINAL ARTICLE Pages: 88 - 92
Intrapleural instillation of interferon γ in patients with malignant pleurisy due to lung cancer H. YanagawaTakashi HakuSaburo Sone ORIGINAL ARTICLE Pages: 93 - 99
Antitumor effects of the combination immunotherapy with interleukin-12 and tumor necrosis factor α in mice W. LasekWojciech FeleszkoMarek Jakóbisiak ORIGINAL ARTICLE Pages: 100 - 108
Active and indolent chronic lymphocytic leukaemia – immune and hormonal peculiarities H. EverausE. LuikJane Lehtmaa ORIGINAL ARTICLE Pages: 109 - 114
The antitumor effects of levamisole in mice are mediated by NC-1.1+ cells Gregory R. ClarkeRobert C. BurtonY. Cheng Smart SHORT COMMUNICATION Pages: 115 - 118
Active immunization of metastatic melanoma patients with interleukin-2-transduced allogeneic melanoma cells: evaluation of efficacy and tolerability Filiberto BelliFlavio ArientiG. Parmiani ERRATUM Pages: 119 - 119
